CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Liposonix System (Model 2)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01853397
NCT01853397N/ACompleted
CompareCT.gov

An Evaluation of the Safety and Effectiveness of Treatment of Adipose Tissue With the Liposonix System (Model 2) Using a New Treatment Method

Solta Medical·interventional·Posted May 15, 2013·Updated Apr 16, 2015

In Brief

A clinical study evaluating Liposonix System (Model 2) for Subcutaneous Adipose Tissue. Completed, enrolled 72 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubcutaneous Adipose Tissue
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 15, 2013
Enrollment StartApr 1, 2013
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.1 years ago

Interventions

Liposonix System (Model 2)device